LEGN
33.56
-1.16 (-3.34%)
Legend Biotech Corp. Sponsored ADR · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website legendbiotech.com
- Employees(FY) 1700
- ISIN US52490G1022
Performance
+3.29%
1W
-19.44%
1M
-31.61%
3M
-27.52%
6M
+3.13%
YTD
-42.28%
1Y
Profile
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery, development, manufacturing, and commercialization of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multiple myeloma (MM). The company also has a portfolio of earlier-stage autologous CAR-T product candidates targeting various cancers, including Non-Hodgkins Lymphoma, acute lymphoblastic leukemia , gastric cancer, esophageal cancer, pancreatic cancer, colorectal cancer, hepatocellular carcinoma, small cell lung cancer, and non-small cell lung cancer. It has collaboration and license agreement with Janssen Biotech, Inc. for the development and commercialization of ciltacabtagene autoleucel. Legend Biotech Corporation was founded in 2014 and is based in Somerset, New Jersey. Legend Biotech Corporation is a subsidiary of Genscript Biotech Corporation.
Technical Analysis of LEGN 2025-01-07
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2025-01-02 07:50
Karyopharm Therapeutics Names Lori Macomber CFO(MT Newswires)
- 2024-12-24 12:38
Top Midday Decliners(MT Newswires)
- 2024-12-24 11:36
- 2024-12-23 09:06
Exploring 3 High Growth Tech Stocks In The United States(Simply Wall St.)
- 2024-12-19 08:01
- 2024-12-18 19:01
- 2024-12-11 07:22
- 2024-12-10 05:17
- 2024-12-09 19:35
- 2024-12-09 10:50
Arcellx And Legend Bio Trade Jabs In Multiple Myeloma. But Only One Pulls Ahead.(Investor's Business Daily)
- 2024-12-09 09:04
- 2024-12-09 06:35
- 2024-11-27 10:02
- 2024-11-21 18:31
- 2024-11-21 17:28
- 2024-11-21 09:02
High Growth Tech Stocks in the United States to Watch(Simply Wall St.)
- 2024-11-15 08:12
- 2024-11-14 08:11
- 2024-11-13 03:28
Q3 2024 Legend Biotech Corp Earnings Call(Thomson Reuters StreetEvents)
- 2024-11-13 02:07
- 2024-11-12 09:30
- 2024-11-12 07:45
Legend Biotech Q3 Loss Widens, Revenue Rises(MT Newswires)
- 2024-11-12 07:00
- 2024-11-11 18:00
- 2024-11-11 09:55
- 2024-11-11 07:04
- 2024-11-07 07:30
- 2024-11-06 18:30
- 2024-11-05 09:10
- 2024-11-04 20:10
Page 1 of 9
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.